THE INTERFACE
The molecular border between blood and tissue
The endothelial glycocalyx is a gel-like layer covering the blood-facing surface of the endothelium. It contains glycosaminoglycans, proteoglycans, glycoproteins, heparan sulfate, chondroitin sulfate, hyaluronan, membrane proteins and bound plasma components.
It participates in permeability control, mechanotransduction, nitric-oxide signalling, leukocyte adhesion, platelet interaction, coagulation regulation, fluid exchange, endothelial protection and inflammatory control. Damage and shedding expose the endothelial surface beneath it.
The glycocalyx is not decoration on the endothelium. It is part of the vascular organ.
Four states of the interface
Select a state to see how endothelial exposure, permeability, platelet proximity, leukocyte adhesion, inflammatory signalling, shear-stress sensing and nitric-oxide response change with the condition of the layer. The fourth state is a research hypothesis — it does not imply that every effect shown is reversed by sulodexide in patients.
Healthy
An intact glycocalyx keeps circulating cells and large plasma molecules at a distance from the endothelial surface, supports shear-stress sensing and nitric-oxide response, and limits leukocyte adhesion and permeability.
- Endothelial exposure: minimal — the surface is covered
- Permeability: controlled fluid and protein exchange
- Platelet proximity: kept at distance
- Leukocyte adhesion: low
- Shear-stress sensing and NO response: intact
Partially damaged
Partial shedding thins the layer. The endothelial surface becomes intermittently exposed; permeability and inflammatory signalling begin to rise, and circulating cells approach the wall more easily.
- Endothelial exposure: intermittent gaps in the layer
- Permeability: rising fluid and protein leakage
- Platelet proximity: increased wall contact
- Leukocyte adhesion: increased at exposed sites
- Inflammatory signalling: activated
Severely shed
Severe shedding strips the interface. The endothelium is broadly exposed: barrier behaviour, mechanotransduction and NO signalling are impaired, and the surface becomes available for cellular adhesion and coagulation interaction.
- Endothelial exposure: broad, sustained exposure
- Permeability: markedly increased leakage
- Platelet proximity: direct wall interaction possible
- Leukocyte adhesion: elevated
- Shear-stress sensing and NO response: impaired
Conceptual repair environment
The research question: whether an environment rich in glycosaminoglycan fractions can support the interface — through incorporation, protection against degradation, or reduced shedding. Human and experimental studies have reported effects on glycocalyx-related measurements; the mechanism and its limits remain open.
- Endothelial exposure: reduced — conceptual, not established
- Permeability: improved in experimental models
- Glycocalyx dimensions: changes observed in a small human mechanistic study
- Mechanism: incorporation vs protection vs reduced shedding — unresolved
- Status: an active Panacea research question, not a demonstrated clinical effect
Where sulodexide research fits
Published human research in people with type 2 diabetes reported changes in measured sublingual and retinal glycocalyx dimensions following oral sulodexide administration. This was a limited mechanistic study and must not be described as proof that sulodexide universally regenerates the human vascular system.
Experimental work adds context: nitric-oxide-mediated relaxation in isolated vessels, and permeability improvement via glycocalyx remodelling in endothelial-cell and animal sepsis models. Each layer has its own evidence tier — this site labels them separately rather than blending them into one claim.